Compare
LogicMark, Inc. vs Milestone Scientific Inc. vs Lifeward Ltd. vs Myomo, Inc.
| Latest fiscal year | LogicMark, Inc. LGMK | Milestone Scientific Inc. MLSS | Lifeward Ltd. LFWD | Myomo, Inc. MYO |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $11.43M | $8.97M | $22.03M | $40.93M |
| Revenue growth (YoY) | +15.4% | +4.0% | -14.1% | +25.7% |
| Gross margin | 66.8% | 71.4% | 38.2% | 65.7% |
| Operating margin | -69.1% | -63.5% | -89.3% | -35.2% |
| Net margin | -65.4% | -63.8% | -90.4% | -38.1% |
| Net income | -$7.47M | -$5.72M | -$19.91M | -$15.57M |
| EPS (Diluted) | -$13.06 | -$0.07 | -$17.16 | -$0.37 |
| Operating cash flow | -$5.06M | -$2.92M | -$16.83M | -$14.51M |
| Free cash flow | -$5.13M | -$2.93M | -$16.84M | -$16.25M |
| Cash & equivalents | $3.57M | $1.11M | $2.17M | $14.13M |
| Total assets | $20.31M | $7.81M | $22.90M | $38.64M |
| Total liabilities | $2.22M | $4.99M | $14.49M | $27.23M |
| Shareholders' equity | $16.28M | $2.81M | $8.41M | $11.40M |
| Return on year-end equity | -45.9% | -203.4% | -236.8% | -136.6% |
| Shares outstanding | 906.1K | 80.45M | 1.52M | 38.47M |
Revenue, most recent five fiscal years
| Fiscal year | LogicMark, Inc. | Milestone Scientific Inc. | Lifeward Ltd. | Myomo, Inc. |
|---|---|---|---|---|
| Latest | $11.43M Ended 2025-12-31 | $8.97M Ended 2025-12-31 | $22.03M Ended 2025-12-31 | $40.93M Ended 2025-12-31 |
| 1 year earlier | $9.90M Ended 2024-12-31 | $8.63M Ended 2024-12-31 | $25.66M Ended 2024-12-31 | $32.55M Ended 2024-12-31 |
| 2 years earlier | $9.93M Ended 2023-12-31 | $9.83M Ended 2023-12-31 | $13.85M Ended 2023-12-31 | $19.24M Ended 2023-12-31 |
| 3 years earlier | $11.92M Ended 2022-12-31 | $8.81M Ended 2022-12-31 | $5.51M Ended 2022-12-31 | $15.56M Ended 2022-12-31 |
| 4 years earlier | $10.02M Ended 2021-12-31 | $10.30M Ended 2021-12-31 | $5.97M Ended 2021-12-31 | $13.86M Ended 2021-12-31 |